Updated results: A phase InIa randomized trial of radium-223 + docetaxel versus docetaxel in patients with castration-resistant prostate cancer and bone metastases Meeting Abstract
| Authors: | Morris, M. J.; Loriot, Y.; Sweeney, C.; Fizazi, K.; Ryan, C. J.; Shevrin, D. H.; Antonarakis, E. S.; Reeves, J.; Chandrawansa, K.; Kornacker, M.; Higano, C. S. |
| Abstract Title: | Updated results: A phase InIa randomized trial of radium-223 + docetaxel versus docetaxel in patients with castration-resistant prostate cancer and bone metastases |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 284s |
| Language: | English |
| ACCESSION: | WOS:000404711501052 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.5075 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5075 -- Source: Wos |
